All Issue

2025 Vol.55, Issue 3

Review Article

Clonal Dynamics and Antimicrobial Resistance of blaOXA-23-Harboring Carbapenem-Resistant Acinetobacter baumannii Isolates in a Korean Hospital, 2004-2018
Shukho Kim12
,
Chung-Young Lee12
,
Minsang Shin12
,
Seong-Jun Kim12
,
Jungmin Kim12
,
Je Chul Lee12*
1Department of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea
2Untreatable Infectious Disease Institute, Kyungpook National University, Daegu 41944, Republic of Korea
*leejc@knu.ac.kr
30 September 2025. pp. 197-204
PDF XML Citation
Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant clinical challenge due to its epidemic potential and resistance to multiple antimicrobial agents. In Korea, blaOXA-23 has been the predominant carbapenemase gene identified in CRAB strains since its initial detection in the early 2000s. This review analyzed the clonal evolution and antimicrobial resistance of blaOXA-23-harboring CRAB isolates collected from a tertiary hospital in Daegu between 2004 and 2018. Over this 15-year period, substantial changes in sequence types (STs), based on the Oxford multilocus sequence typing scheme, were observed. ST353 blaOXA-23-harboring CRAB isolates were first detected in 2004, followed by a predominance of ST92 in the mid-2000s. From 2012, ST191 and ST208 showed marked clonal expansion. Beginning in 2013, newer clones such as ST229, ST369, ST451, and ST784 emerged and gradually replaced earlier clonal lineages. These clonal shifts were primarily driven by allelic variation, particularly in the gpi gene. While most CRAB isolates exhibited an extensively drug-resistant phenotypes, susceptibility to colistin and tigecycline was largely retained. Antimicrobial resistance profiles varied by clone; for example, ST369 CRAB isolates were relatively more susceptible to aminoglycosides and trimethoprim-sulfamethoxazole. All CRAB isolates possessed the ISAba1-blaOXA-23 genetic structure. The 16S rRNA methyltransferase gene armA was frequently detected in ST191, ST208, ST451, and ST784 CRAB, but was uncommon in ST369. These findings highlight the ongoing clonal evolution of CRAB in clinical settings and emphasize the importance of continuous molecular surveillance.

Keywords
Acinetobacter baumannii
Carbapenem resistance
OXA-23 carbapenemase
Clonal dynamics
Sequence type
References
1

Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48(10):6987-6998.

10.1007/s11033-021-06690-634460060PMC8403534
2

Vazquez-Lopez R, Solano-Galvez SG, Juarez Vignon-Whaley JJ, Abello Vaamonde JA, Padro Alonzo LA, Rivera Resendiz A, et al. Acinetobacter baumannii resistance: A real challenge for clinicians. Antibiotics. 2020;9(4):205.

10.3390/antibiotics904020532340386PMC7235888
3

Nasr P. Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii. J Hosp Infect. 2019;104(1):4-11.

10.1016/j.jhin.2019.09.021
4

Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079-1081.

10.1086/533452
5

Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.

10.3389/fcimb.2017.0005528348979PMC5346588
6

Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16(1):35-40.

10.3201/eid1601.09085220031040PMC2874364
7

Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F, et al. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022;50(1):83-92.

10.1007/s15010-021-01643-434176088PMC8236000
8

WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization. Geneva, Switzwerland. 2024.

9

Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;10(3):373.

10.3390/pathogens1003037333808905PMC8003822
10

Raible KM, Sen B, Law N, Bias TE, Emery CL, Ehrlich GD, et al. Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob. 2017;16(1):75.

10.1186/s12941-017-0248-329145853PMC5691885
11

Heo ST, Oh WS, Kim SJ, Bae IG, Ko KS, Lee JC. Clinical impacts of a single clone (sequence type 92) of multidrug-resistant Acinetobacter baumannii in intensive care units. Microb Drug Resist. 2011;17(4):559-562.

10.1089/mdr.2011.0087
12

Ayoub Moubareck C, Hammoudi Halat D, Nabi A, AlSharhan MA, AlDeesi ZO, Han A, et al. Detection of OXA-23, GES-11 and NDM-1 among carbapenem-resistant Acinetobacter baumannii in Dubai: a preliminary study. J Glob Antimicrob Resist. 2021;24:27-28.

10.1016/j.jgar.2020.11.016
13

Maamar E, Alonso CA, Ferjani S, Jendoubi A, Hamzaoui Z, Jebri A, et al. NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia. Int J Antimicrob Agents. 2018;52(6): 910-915.

10.1016/j.ijantimicag.2018.04.008
14

Rafei R, Osman M, Dabboussi F, Hamze M. Update on the epidemiological typing methods for Acinetobacter baumannii. Future Microbiol. 2019;14:1065-1080.

10.2217/fmb-2019-0134
15

Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B. Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4328-4335.

10.1128/JCM.43.9.4328-4335.200516145073PMC1234071
16

Da Silva G, Dijkshoorn L, van der Reijden T, van Strijen B, Duarte A. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect. 2007;13(2): 190-195.

10.1111/j.1469-0691.2006.01628.x
17

Bartual SG. Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4382-4390.

10.1128/JCM.43.9.4382-4390.200516145081PMC1234098
18

Higgins PG, Prior K, Harmsen D, Seifert H. Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS One. 2017;12(6):e0179228.

10.1371/journal.pone.017922828594944PMC5464626
19

Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: Expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010;5(4):e10034.

10.1371/journal.pone.001003420383326PMC2850921
20

Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65(2):233-238.

10.1093/jac/dkp428
21

Van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, van den Broek P, et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol. 2004;155(2):105-112.

10.1016/j.resmic.2003.10.003
22

Shelenkov A, Akimkin V, Mikhaylova Y. International clones of high risk of Acinetobacter baumannii-definitions, history, properties and perspectives. Microorganisms. 2023;11(8):2115.

10.3390/microorganisms1108211537630675PMC10459012
23

Hawkey J, Ascher DB, Judd LM, Wick RR, Kostoulias X, Cleland H, et al. Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection. Microb Genom. 2018;4(3):e000165.

10.1099/mgen.0.00016529547094PMC5885017
24

Jun SH, Lee DE, Hwang HR, Kim N, Kim HJ, Lee YC, et al. Clonal change of carbapenem-resistant Acinetobacter baumannii isolates in a Korean hospital. Infect Genet Evol. 2021;93:104935.

10.1016/j.meegid.2021.104935
25

Selasi GN, Nicholas A, Jeon H, Lee YC, Yoo JR, Heo ST, et al. Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol. 2015;36:1-7.

10.1016/j.meegid.2015.09.001
26

Jeon H, Kim S, Kim MH, Kim SY, Nam D, Park SC, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from a Korean hospital that carry blaOXA-23. Infect Genet Evol. 2018;58:232-236.

27

Gurung M, Rho JS, Lee YC, Kim HS, Moon SY, Yu BH, et al. Emergence and spread of carbapenem resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect Genet Evol. 2013;19:219-222.

10.1016/j.meegid.2013.07.016
28

Turner PJ. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002). Diagn Microbiol Infect Dis. 2005;51(4):281-289.

10.1016/j.diagmicrobio.2004.11.013
29

Turner PJ. Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis. 2008;60(2):185-192.

10.1016/j.diagmicrobio.2007.09.006
30

Lee K, Lee HS, Jang SJ, Park AJ, Lee MH, Song WK, et al. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J Korean Med Sci. 2001;16(3):262-270.

10.3346/jkms.2001.16.3.26211447969PMC3054736
31

Bae IK, Hong JS. The distribution of carbapenem-resistant Acinetobacter species and high prevalence of CC92 OXA-23-producing Acinetobacter baumannii in community hospitals in South Korea. Infect Drug Resist. 2024;17: 1633-1641.

10.2147/IDR.S45973938707988PMC11068040
32

Shin KS, Son BR, Koo SH, Lee SH, Ahn JB, Park SH, et al. Evaluation of dipicolinic acid-based Mueller Hinton agar biplate for detection of IMP-1 and VIM-2 type metallo-β-lactamase in imipenem non-susceptible gram negative bacilli. Korean J Lab Med. 2009;29(3):204-211.

10.3343/kjlm.2009.29.3.204
33

Jeong SH. Mechanisms of acquiring carbapenem-resistance in Acinetobacter species. Korean J Clin Microbiol. 2009;12(1):1-5.

10.5145/KJCM.2009.12.1.1
34

Chong Y, Lee K. Present situation of antimicrobial resistance in Korea. J Infect Chemother. 2000;6(4):189-195.

10.1007/s101560070001
35

Oh JY, Lee JC. Integron carriage in multiresistant Acinetobacter baumannii strains. J Bacteriol Virol. 2003;33(4): 245-251.

36

Figueiredo S, Bonnin RA, Poirel L, Duranteau J, Nordman P. Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus. Clin Microbiol Infect. 2012;18(9):907-913.

10.1111/j.1469-0691.2011.03708.x
37

Paton R, Miles RS, Hood J, Amyes SG, Miles RS, Amyes SG. ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 1993;2(2):81-87.

10.1016/0924-8579(93)90045-7
38

Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem- resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol. 2005;43(5):2241-2245.

10.1128/JCM.43.5.2241-2245.200515872249PMC1153754
39

Lee JH, Choi CH, Kang HY, Lee JY, Kim J, Lee YC, et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother. 2007;59(4):633-639.

10.1093/jac/dkm007
40

Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn Microbiol Infect. Dis. 2009;64(2):185-190.

10.1016/j.diagmicrobio.2009.02.010
41

Park YK, Choi JY, Jung SI, Park KH, Lee H, Jung DS, et al. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn Microbiol Infect Dis. 2009;64(4):389-395.

10.1016/j.diagmicrobio.2009.03.029
42

Park YK, Jung SI, Park KH, Kim DH, Choi JY, Kim SH, et al. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years. J Med Microbiol. 2012;61(Pt 1):71-79.

10.1099/jmm.0.033852-0
43

Lee Y, Lee J, Jeong SH, Lee J, Bae IK, Lee K. Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene. J Antimicrob Chemother. 2011;66(1):66-72.

10.1093/jac/dkq402
44

Kim MH, Jeong H, Sim YM, Lee S, Yong D, Ryu CM, et al. Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications. PLoS One. 2020;15(2):e0229416.

10.1371/journal.pone.022941632084241PMC7034955
45

Son HJ, Cho EB, Bae M, Lee SC, Sung H, Kim MN, et al. Clinical and Microbiological analysis of risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia. Open Forum Infect Dis. 2020;7(10):ofaa378.

10.1093/ofid/ofaa37833072809PMC7539690
46

Yoon EJ, Kim D, Lee H, Lee HS, Shin JH, Uh Y, et al. Counter clinical prognoses of patients with bloodstream infections between causative Acinetobacter baumannii clones ST191 and ST451 belonging to the international clonal lineage II. Front Public Health. 2019;7:233.

10.3389/fpubh.2019.0023331475131PMC6707333
Information
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • Volume : 55
  • No :3
  • Pages :197-204
  • Received Date : 2025-06-18
  • Revised Date : 2025-06-25
  • Accepted Date : 2025-08-06
  • DOI :https://doi.org/10.4167/jbv.2025.55.3.197
Journal Informaiton JOURNAL OF BACTERIOLOGY AND VIROLOGY JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • NRF
  • 임플란트학회 전용 배너
  • KOFST
  • crossref crossmark
  • crossref cited-by
  • crossref funder-registry
  • crosscheck
  • orcid
  • open access
  • ccl
Journal Informaiton Journal Informaiton - close